Innate immunity in cystic fibrosis lung disease

被引：179

作者：

Hartl, D. ^{[1
]}

Gaggar, A. ^{[2
,3
]}

Bruscia, E. ^{[4
]}

Hector, A. ^{[1
]}

Marcos, V. ^{[5
]}

Jung, A. ^{[6
]}

Greene, C. ^{[7
]}

McElvaney, G. ^{[7
]}

Mall, M. ^{[8
,9
]}

Doering, G.

机构：

[1] Univ Tubingen, Dept Pediat 1, Tubingen, Germany

[2] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

[3] Univ Alabama Birmingham, Dept Physiol Biophys, Birmingham, AL USA

[4] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA

[5] Univ Munich, Dept Pediat, Munich, Germany

[6] Univ Childrens Hosp, Dept Resp Med, Zurich, Switzerland

[7] Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Resp Res Div, Dublin 9, Ireland

[8] Heidelberg Univ, Div Pediat Pulmonol & Allergy, Heidelberg, Germany

[9] Heidelberg Univ, Cyst Fibrosis Ctr, Dept Pediat 3, Heidelberg, Germany

来源：

JOURNAL OF CYSTIC FIBROSIS | 2012年 / 11卷 / 05期

关键词：

Cystic fibrosis; Lung disease; Bacteria; Immunity; Innate immunity; Pattern recognition; Host defense; Chemokines; Toll-like receptors; Neutrophils; Macrophages; Phagocytosis; Migration; IL-17; PGP; Pseudomonas; TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-2; PSEUDOMONAS-AERUGINOSA INFECTION; PATTERN-RECOGNITION RECEPTORS; HUMAN MONOCYTES DEMONSTRATION; POTENT PHAGOCYTIC-ACTIVITY; BINDING LECTIN MBL;

D O I：

10.1016/j.jcf.2012.07.003

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Chronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients. The pulmonary immune response in CF is characterized by an early and non-resolving activation of the innate immune system, which is dysregulated at several levels. Here we provide a comprehensive overview of innate immunity in CF lung disease, involving (i) epithelial dysfunction, (ii) pathogen sensing, (iii) leukocyte recruitment, (iv) phagocyte impairment, (v) mechanisms linking innate and adaptive immunity and (iv) the potential clinical relevance. Dissecting the complex network of innate immune regulation and associated pro-inflammatory cascades in CF lung disease may pave the way for novel immune-targeted therapies in CF and other chronic infective lung diseases. (C) 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

引用

页码：363 / 382

页数：20

共 50 条

[41] Single nucleotide polymorphisms in genes of the innate immunity in cystic fibrosis patients: correlation with lung function and Pseudomonas aeruginosa colonisation
Haerynck, F.
Schelstraete, P.
Van daele, S.
Rossau, R.
De Baets, F.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 50 - 50
[42] Pseudomonas aeruginosa Exploits Lipid A and Muropeptides Modification as a Strategy to Lower Innate Immunity during Cystic Fibrosis Lung Infection
Cigana, Cristina
Curcuru, Laura
Leone, Maria Rosaria
Ierano, Teresa
Lore, Nicola Ivan
Bianconi, Irene
Silipo, Alba
Cozzolino, Flora
Lanzetta, Rosa
Molinaro, Antonio
Bernardini, Maria Lina
Bragonzi, Alessandra
PLOS ONE, 2009, 4 (12):
[43] INNATE IMMUNITY AND HEPATIC FIBROSIS
Friedman, S. L.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 33 (06) : 273A - 273A
[44] Innate Immunity in Lung Fibrosis: A Therapeutic Role for Surfactant Protein D?
Scotton, Chris J.
Chambers, Rachel C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (05) : 471 - 473
[45] Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis
O'Dwyer, David N.
Ashley, Shanna L.
Moore, Bethany B.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2016, 311 (03) : L590 - L601
[46] Tissue Repair In Cystic Fibrosis Lung Disease
Maharaj, S. S.
Baroke, E.
Duan, F.
Freitag, A.
Welte, T.
Gauldie, J.
Kolb, M. R. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[47] Clinical presentation of lung disease in cystic fibrosis
Stahl, Mirjam
RADIOLOGE, 2020, 60 (09): : 774 - 780
[48] Cystic fibrosis lung disease: Current perspectives
Jung, Jin-A
ALLERGY ASTHMA & RESPIRATORY DISEASE, 2020, 8 (01): : 3 - 8
[49] Antioxidant supplementation for lung disease in cystic fibrosis
Ciofu, Oana
Smith, Sherie
Lykkesfeldt, Jens
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (10):
[50] Role of corticosteroids in cystic fibrosis lung disease
BalfourLynn, IM
Dinwiddie, R
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1996, 89 : 8 - 13

← 1 2 3 4 5 →